Dapagliflozin reduced the combined risk of worsening heart failure
Dapagliflozin reduced the combined risk of worsening heart failure or cardiovascular death among patients with heart failure and a mildly reduced or preserved ejection fraction.
Newsletter Signup
Subscribe to our weekly newsletter below and never miss the latest product or an exclusive offer.